Trial Profile
Comparison of an overnight switch to everolimus-based immunosuppression versus continuation of ciclosporin-based immunosuppression in renal transplant recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Immunosuppressants
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 28 Sep 2011 New trial record
- 07 Sep 2011 Results presented at the 15th Congress of the European Society for Organ Transplantation.